BioSpace News Archive

Press Releases

Immunovant Announces Oral Presentation of Late Breaking Abstract for Phase 2 Graves’ Disease Clinical Data at the 2024 American Thyroid Association (ATA) Annual Meeting

October 29, 2024
·
1 min read
Press Releases

Monopar Therapeutics Inc. Announces Pricing of $19.2 Million Public Offering of Common Stock

October 29, 2024
·
4 min read
Press Releases

First Patient In - BioPorto Initiates Patient Enrollment for US Study of ProNephro AKI (NGAL)™ for Adult Use at Massachusetts General Hospital

October 29, 2024
·
5 min read
Press Releases

MAIA Biotechnology Announces $2.44 Million Private Placement

October 29, 2024
·
4 min read
Press Releases

MedLumics New CEO and Board Member Announces 10 Patients Treated in First in Man (FIM) Clinical Trial With the Real-Time Visually Guided AblaView PFA System

October 29, 2024
·
6 min read
Press Releases

GlycoMimetics Enters Into Acquisition Agreement With Crescent Biopharma

October 29, 2024
·
15 min read
Press Releases

Iambic Therapeutics Announces “Enchant,” an AI Platform that Predicts Clinical Outcomes from the Earliest Stages of Drug Discovery

October 29, 2024
·
4 min read
Press Releases

Abeona Therapeutics® Completes Pz-cel Biologics License Application Resubmission to U.S. Food and Drug Administration

October 29, 2024
·
5 min read
Press Releases

Kiniksa Pharmaceuticals Reports Third Quarter 2024 Financial Results and Recent Portfolio Execution

October 29, 2024
·
11 min read
Press Releases

Zai Lab Reports Positive Topline Data from Phase 3 Bridging Trial Evaluating KarXT for the Treatment of Schizophrenia in China

October 29, 2024
·
8 min read